Jesper Bøje Andersen

Jesper Bøje Andersen

Professor

ORCID: 0000-0003-1760-5244

Publication year:
All
1 - 10 out of 14Page size: 10
Sort by: 1st author
  1. Published

    Epigenetic events involved in organic cation transporter 1-dependent impaired response of hepatocellular carcinoma to sorafenib

    Al-Abdulla, R., Lozano, E., Macias, R. I. R., Monte, M. J., Briz, O., O'Rourke, Colm, Serrano, M. A., Banales, J. M., Avila, M. A., Martinez-Chantar, M. L., Geier, A., Andersen, Jesper Bøje & Marin, J. J. G., 2019, In: British Journal of Pharmacology. 176, 6, p. 787-800

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    Cholangiocarcinoma: State-of-the-art knowledge and challenges

    Banales, J. M., Cardinale, V., Macias, R. I. R., Andersen, Jesper Bøje, Braconi, C., Carpino, G., Alvaro, D. & Calvisi, D. F., 2019, In: Liver International. 39, S1, p. 5-6 2 p.

    Research output: Contribution to journal › Editorial › Research › peer-review

  3. Published

    Molecular Perturbations in Cholangiocarcinoma: Is it Time for Precision Medicine?

    Braconi, C., Roessler, S., Kruk, B., Lammert, F., Krawczyk, M. & Andersen, Jesper Bøje, 2019, In: Liver International. 39, Suppl. 1, p. 32-42 11 p.

    Research output: Contribution to journal › Review › Research › peer-review

  4. Published

    Application of patient-derived liver cancer cells for phenotypic characterization and therapeutic target identification

    Castven, D., Becker, D., Czauderna, C., Wilhelm, D., Andersen, J. B., Strand, S., Hartmann, M., Heilmann-Heimbach, S., Roth, W., Hartmann, N., Straub, B. K., Mahn, F. L., Franck, S., Pereira, S., Haupts, A., Vogel, A., Wörns, M. A., Weinmann, A., Heinrich, S., Lang, H. & 3 others, Thorgeirsson, S. S., Galle, P. R. & Marquardt, J. U., 2019, In: International Journal of Cancer. 144, 11, p. 2782-2794 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells

    Di Maira, G., Gentilini, A., Pastore, M., Caligiuri, A., Piombanti, B., Raggi, C., Rovida, E., Lewinska, Monika, Andersen, Jesper Bøje, Borgo, C., Salvi, M., Ottaviani, D., Ruzzene, M. & Marra, F., 2019, In: Oncogenesis. 8, 11, p. 61-72 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Causes of hOCT1-dependent cholangiocarcinoma resistance to sorafenib and sensitization by tumor-selective gene therapy

    Lozano, E., Macias, R. I. R., Monte, M. J., Asensio, M., Del Carmen, S., Sanchez-Vicente, L., Alonso-Peña, M., Al-Abdulla, R., Munoz-Garrido, P., Satriano, L., O'Rourke, Colm, Banales, J. M., Avila, M. A., Martinez-Chantar, M. L., Andersen, Jesper Bøje, Briz, O. & Marin, J. J. G., Oct 2019, In: Hepatology. 70, 4, p. 1246-1261 16 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Ganglioside composition correlates with the malignant phenotype of cholangiocarcinoma cells and modulates cell adhesion

    Mannini, A., Raggi, C., Correnti, M., Rovida, E., Andersen, Jesper Bøje, Coulouarn, C. & Marra, F., 2019, In: Digestive and Liver Disease. 51, p. e7

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  8. Published

    Epigenome Remodeling in Cholangiocarcinoma

    O'Rourke, Colm, Lafuente Barquero, Juan Francisco & Andersen, Jesper Bøje, 2019, In: Trends in Cancer. 5, 6, p. 335-350 16 p.

    Research output: Contribution to journal › Review › Research › peer-review

  9. Published

    Therapeutic Potential of Pharmacoepigenetics in Cholangiocarcinoma

    O'Rourke, Colm, Satriano, L., Oliveira, D. V. N. P., Munoz-Garrido, P. & Andersen, Jesper Bøje, 2019, Pharmacoepigenetics. Academic Press, p. 551-562 12 p.

    Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review

  10. Published

    Acquisition of stem-like features in human cholangiocarcinoma is associated with an oxidative metabolism

    Raggi, C., Navari, N., Taddei, M. L., Sacco, E., Correnti, M., Piombanti, B., Andersen, Jesper Bøje, Ramazzotti, M., Orlandi, I., Chiarugi, P. & Marra, F., 2019, In: Digestive and Liver Disease. 51, e34.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Previous 1 2 Next

ID: 93714085